Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-05

Clinical Trial Update: Investigation of Femoropopliteal In Situ Valve Formation With the InterVene System (INFINITE-Canada) [NA]

View source ↗

Summary

The INFINITE-Canada trial investigating the InterVene System for femoropopliteal in situ valve formation in chronic venous insufficiency has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • InterVene System

Snippet

Sponsor: Intervene, Inc. | Conditions: Chronic Venous Insufficiency | NA | Status: WITHDRAWN